US FDA approves gradual dosing for Lilly Alzheimer's drug – Reuters

1. US FDA approves gradual dosing for Lilly Alzheimer’s drug  Reuters
2. FDA approves new dosing of Lilly’s Alzheimer’s drug Kisunla to lower brain swelling risks  Endpoints News
3. Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns  BioSpace
4. FDA approves updated dosing for Lilly’s Kisunla Alzheimer’s treatment  StreetInsider
5. FDA approves new dosing schedule for Lilly’s Alzheimer’s drug Kisunla  Investing.com

Continue Reading